Advancing health with precision across therapies and technologies
We develop next-generation delivery platforms and clinically validated products to improve outcomes responsibly and at scale.
Patients first
Access, safety, and transparency drive our work.
Platform innovation
PQNS™ ensures superior bioavailability and tolerability.
Partnerships
Collaboration accelerates translation and impact.
Deliver more with less: PQNS enables lower dosing with maintained efficacy
Our delivery platform improves stability and intestinal tolerance while enabling controlled release—demonstrated across multiple actives.
Solutions across Pharma & Nutraceuticals
Two complementary divisions—Pharma with evidence-based prescription therapies, and Nutraceuticals enhanced by PQNS for superior bioavailability and tolerance.
Prescription therapies aligned to clinical endpoints
Evidence-based Rx molecules and combinations designed for lipid control, glycemia, inflammation, and cardiovascular risk—integrated with monitoring and adherence.
- Axis-driven selection (lipids, glucose, inflammation, CV)
- Formulation support & CDMO partnerships
- Quality systems and regulatory documentation
Clinical-grade nutraceuticals with superior bioavailability
PQNS-enabled formulations that achieve higher plasma exposure at lower doses—engineered for gut-friendly, sustained benefit.
- PQNS delivery (Protection • Programmability • Precision)
- Category lines: Joint, Anti-inflammatory, Mitochondria, Women’s Health
- Digital adherence & reward integration
PQNS technology
Next-generation delivery engineered for higher bioavailability and consistent, gut-friendly performance.
Technology schematic
Clinically demonstrated to achieve greater plasma exposure than widely used formulations.
Featured products
Q-Synovi™
Joint health solution—16 synergistic actives encapsulated in phospholipid nano-spheres for 85–90% uptake and >90% stability.
Icovasc™
Highly purified EPA for triglyceride reduction and CV risk lowering in select high-risk patients as an adjunct to statin therapy.
RiboNad+® Longevity
Supports healthy aging with NAD+ boosting, antioxidant defense, and clinically backed cellular repair.
Latest highlights
Updates from research, partnerships, and our communities.
Q-Curviva™ with PQNS: Faster Onset, Sustained Plasma Exposure, Enhanced Absorption, Superior Clinical Potential
New softgel line commissioned for PQNS-enabled capsules
RiboNad+ will be launched soon, supported by an adherence program and patient reward system.
Partner with Crassula
From formulation to scale—CDMO engagements leveraging PQNS and our capsule/softgel platforms.
Integrated Care Model
We think in systems: prevention, diagnosis, therapy, and monitoring.
Prevention
Lifestyle-aligned protocols and evidence-based supplementation.
Diagnosis
Partner pathways for labs and screening tools.
Therapy
Formulations designed to complement standard of care.
Join us in building patient-centered science
Explore open roles in R&D, manufacturing, clinical affairs, and more.